Steroid Pulse Therapy for Children With Intravenous Immunoglobulin Therapy–Resistant Kawasaki Disease: A Prospective Study

被引:0
|
作者
Masayuki Teraguchi
Hirotaro Ogino
Ken Yoshimura
Shoichiro Taniuchi
Minoru Kino
Hitoshi Okazaki
Kazunari Kaneko
机构
[1] Kansai Medical University,Department of Pediatrics
[2] Nakano Children’s Hospital,Department of Pediatrics
[3] Kawachi General Hospital,Department of Pediatrics
来源
Pediatric Cardiology | 2013年 / 34卷
关键词
Intravenous immunoglobulin therapy resistant; Kawasaki disease; Prospective study; Steroid pulse therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Patients with Kawasaki disease (KD) who did not respond to the initial IVIG are known to have higher risk for developing coronary arterial lesions (CALs). Our aim is to clarify whether patients with initial IVIG resistant KD may benefit from methylprednisolone pulse therapy (MPT) in comparison with re- treatment of IVIG (2nd IVIG). A total of 237 patients (median age: 2 years 2 months; range 1 months–10 years) with KD were initially treated with IVIG (2 g/kg). Among them, 41 patients (22 %) were assessed as IVIG resistance: these patients were allocated to either group A receiving MPT (n = 14) or group B receiving the 2nd IVIG (n = 27). Patients with resistant to the additional therapy (MPT or 2nd IVIG) were received second IVIG (group A) or MPT (group B). Changes in leukocyte count, C-reactive protein and albumin before and after an additional therapy were significantly greater in group A than those in group B. However, the prevalence of CALs did not differ between the groups (36 % in group A and 26 % in group B, p > 0.05). There was no significant difference in the medical cost between the groups (median cost: 92,032 JPY in group A and 97,331 JPY in group B). MPT does not reduce the risk of development to CAL and does not seem to be beneficial as single agent therapy for IVIG resistant KD.
引用
收藏
页码:959 / 963
页数:4
相关论文
共 50 条
  • [31] Functional mechanism of cyclosporin A therapy for immunoglobulin-resistant Kawasaki disease
    Kakimoto, Nobuyuki
    Suzuki, Hiroyuki
    Suenaga, Tomohiro
    Takeuchi, Takashi
    Shibuta, Shoichi
    Abe, Jun
    Yoshikawa, Norishige
    CIRCULATION, 2015, 131
  • [32] Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study
    Miyata, Koichi
    Kaneko, Tetsuji
    Morikawa, Yoshihiko
    Sakakibara, Hiroshi
    Matsushima, Takahiro
    Misawa, Masahiro
    Takahashi, Tsutomu
    Nakazawa, Maki
    Tamame, Takuya
    Tsuchihashi, Takatoshi
    Yamashita, Yukio
    Obonai, Toshimasa
    Chiga, Michiko
    Hori, Naoaki
    Komiyama, Osamu
    Yamagishi, Hiroyuki
    Miura, Masaru
    LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (12): : 855 - 862
  • [33] A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li, Wei
    He, Xiufang
    Zhang, Li
    Wang, Zhouping
    Wang, Yanfei
    Lin, Huimei
    Yuan, Jia
    Xie, Xiaofei
    Qin, Youzhen
    Huang, Ping
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [34] Intravenous immunoglobulin therapy for resistant ocular Behcet's disease
    Seider, N
    Beiran, I
    Scharf, J
    Miller, B
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (11) : 1287 - 1288
  • [35] Utility of Ferritin as a Predictor of the Patients with Kawasaki Disease Refractory to Intravenous Immunoglobulin Therapy
    Yamamoto, Noboru
    Sato, Kaoru
    Hoshina, Takayuki
    Kojiro, Masumi
    Kusuhara, Koichi
    Kusuhara, Koichi
    CIRCULATION, 2015, 131
  • [36] Parameters to Guide Retreatment After Initial Intravenous Immunoglobulin Therapy in Kawasaki Disease
    Kim, Hyun Kwon
    Oh, Jungeun
    Hong, Young Mi
    Sohn, Sejung
    KOREAN CIRCULATION JOURNAL, 2011, 41 (07) : 379 - 384
  • [37] Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients
    Sato, Satoshi
    Kawashima, Hisashi
    Kashiwagi, Yasuyo
    Hoshika, Akinori
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (02) : 168 - 172
  • [38] Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy
    Yamamoto, Noboru
    Sato, Kaoru
    Hoshina, Takayuki
    Kojiro, Masumi
    Kusuhara, Koichi
    MODERN RHEUMATOLOGY, 2015, 25 (06) : 898 - 902
  • [39] Utility of Ferritin as a Predictor of the Patients with Kawasaki Disease Refractory to Intravenous Immunoglobulin Therapy
    Yamamoto, Noboru
    Sato, Kaoru
    Hoshina, Takayuki
    Kojiro, Masumi
    Kusuhara, Koichi
    Kusuhara, Koichi
    CIRCULATION, 2015, 131
  • [40] Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease
    Bar-Meir, Maskit
    Kalisky, Itai
    Schwartz, Andrei
    Somekh, Eli
    Tasher, Diana
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (01) : 25 - 29